Detection and Measurement of Occult Disease for the Prognosis of Solid Tumors
- 1 July 2003
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (13) , 2609-2615
- https://doi.org/10.1200/jco.2003.01.153
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumorsProceedings of the National Academy of Sciences, 2002
- Epithelial Cells in Bone Marrow of Breast Cancer Patients at Time of Primary Surgery: Clinical Outcome During Long-Term Follow-UpJournal of Clinical Oncology, 2001
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up studyThe Lancet, 1999
- Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cellsProceedings of the National Academy of Sciences, 1999
- Multiple Mutation Analyses in Single Tumor Cells with Improved Whole Genome AmplificationThe American Journal of Pathology, 1999
- Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal StatusJNCI Journal of the National Cancer Institute, 1996
- Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridizationCancer Genetics and Cytogenetics, 1996
- Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma CellsJNCI Journal of the National Cancer Institute, 1993
- Monoclonal Antibodies Detect Occult Breast Carcinoma Metastases in the Bone Marrow of Patients with Early Stage DiseaseThe American Journal of Surgical Pathology, 1988